THX Pharma ALTHX

EURONEXT · France · Health Technology

€3.36-0.06 (-1.61%)

Market open· Oct 1, 2026, 2:58 PM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

THX Pharma ALTHX

EURONEXT · France · Health Technology

€3.36-0.06 (-1.61%)

Market open· Oct 1, 2026, 2:58 PM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

+6.51% · 6MFull-screen chart

Open €3.37High €3.45Low €3.30Close €3.36Volume 69.41K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: €3.41
Day range: €3.30 – €3.45
52-week range: €1.49 – €5.10
Volume: 69.41K
Market cap: €49.23M
Avg. volume (1Y): 124.02K

Performance

1 week

+1.49%

1 month

-17.53%

3 months

+3.02%

6 months

+14.81%

Year to date

+50.22%

1 year

+27.72%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: France
Exchange: EURONEXT
Shares outstanding: 14.44M
ISIN: FR0013286259
Beta: 1.53

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJun 09, 2026

THX Pharma, Biocodex and the Beyond Batten Disease Foundation Stand Together with the CLN3 Batten Community on International Batten Disease Awareness Day

The three partners are proud to jointly serve as Platinum Sponsors of the 2026 BDSRA Annual Family Conference, where they will provide an update on the Batten-1 program and the upcoming initiation of their international pivotal Phase 3 study On the ...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.